Brief: Nova Eye Medical Says FDA Clears Itrack Advance For U.S. Launch
31/03/2023 02:00
March 31 (Reuters) - Nova Eye Medical Ltd EYE.AX :
* FDA CLEARS ITRACK ADVANCE FOR U.S. LAUNCH
Source text for Eikon: ID:nASX9FYF2k
Further company coverage: EYE.AX
((reuters.briefs@thomsonreuters.com;))
Recent news on Nova Eye Medical
See all newsAustralia's Nova Eye Medical jumps on upbeat FY27 earnings guidance
Brief: Nova Eye Medical Reports FY26 Sales Of $23.7 Million
Australia's Nova Eye Medical soars on FY26 sales forecast upgrade
Brief: Nova Eye Medical Upgrades Fy26 Sales Guidance (Ex-China) To $22–23 Million
Australia's Nova Eye Medical rises on EU approval for glaucoma treatment